About this Event
Now more than ever, the drug development model is in need of a drastic shakeup. With lengthy and costly approval processes, generic incursion, rising development costs and the challenge of adherence, pharma and biotech need to innovative product development and delivery to improve therapeutic performance.
Now in it’s 10th successful year (back in both in-person and virtual), the 2023 Controlled & Modified Drug Release Summit will provide you and your team this dose of innovation. Attendees learn directly from industry’s leading experts and hear multiple unique case study sessions and take-home examples to enhance their product pipelines. 2023’s Summit showcases the latest technologies and methods for improving drug release mechanisms, maximizing exposure, and reducing time-to-market. Additionally, this must-attend event will showcase the latest regulatory guidance updates and the implications for the industry.
Connect with 160+ senior drug development innovators in Princeton, NJ this May for industry’s leading drug product development Summit. Attend and and uncover industry’s latest formulation and delivery technologies for improving drug product performance and bioavailability.Benefit from 30+ expert sessions and panels
Are you looking to improve the performance of your drug products? Register to attend today and walk away with game-changing development strategies which could decrease time-to-market and save you millions.
This event is also co-located with the 2023 Global Drug Bioavailability Enhancement Summit. Attendees and sponsors/exhibitors have access to both events!
Event Venue & Nearby Stays
TBC Shortly, TBC Shortly, Princeton, United States
USD 149.00 to USD 1595.00
